JD Health International: Record revenue and profit growth driven by AI healthcare expansion and omnichannel strategy

About this update from Jd Health International, Inc.

Revenue grew 26.3% to RMB73.4 billion in 2025, with non-IFRS profit up 36.3% to RMB6.5 billion and gross margin improving to 24.8%. The company expanded AI-powered healthcare services, launched over 100 new drugs, and strengthened its omnichannel supply chain and direct sales capabilities.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Jd Health International, Inc.